These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28472358)

  • 1. Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine.
    Temporal KH; Scott KS; Mohr ALA; Logan BK
    J Anal Toxicol; 2017 Sep; 41(7):646-657. PubMed ID: 28472358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models.
    Grafinger KE; Stahl K; Wilke A; König S; Weinmann W
    Drug Test Anal; 2018 Oct; 10(10):1607-1626. PubMed ID: 29971945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
    Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
    Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic characterization of 25X-NBOH and 25X-NBOMe phenethylamines based on UHPLC-Q-Exactive Orbitrap MS in human liver microsomes.
    Xiang J; Wen D; Zhai W; Zhao J; Xiang P; Ma C; Shi Y
    J Pharm Biomed Anal; 2024 May; 242():116020. PubMed ID: 38359493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profile determination of 25N-NBOMe in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Seo H; Kim IS; Kim YH; Yoo HH; Hong J
    Int J Legal Med; 2019 May; 133(3):833-841. PubMed ID: 30090972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
    Grafinger KE; Hädener M; König S; Weinmann W
    Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
    Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
    Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
    Caspar AT; Westphal F; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.
    Boumrah Y; Humbert L; Phanithavong M; Khimeche K; Dahmani A; Allorge D
    Drug Test Anal; 2016 Feb; 8(2):248-56. PubMed ID: 26382567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
    Michely JA; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Fate of Hallucinogenic NBOMes.
    Leth-Petersen S; Gabel-Jensen C; Gillings N; Lehel S; Hansen HD; Knudsen GM; Kristensen JL
    Chem Res Toxicol; 2016 Jan; 29(1):96-100. PubMed ID: 26669514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam.
    Moosmann B; Bisel P; Franz F; Huppertz LM; Auwärter V
    J Mass Spectrom; 2016 Nov; 51(11):1080-1089. PubMed ID: 27535017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH.
    Nielsen LM; Holm NB; Leth-Petersen S; Kristensen JL; Olsen L; Linnet K
    Drug Test Anal; 2017 May; 9(5):671-679. PubMed ID: 27400739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
    Tyrkkö E; Pelander A; Ketola RA; Ojanperä I
    Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolites to parent 3-MeO-PCP ratio in human urine collected in two fatal cases.
    Ameline A; Greney H; Monassier L; Raul JS; Kintz P
    J Anal Toxicol; 2019 May; 43(4):321-324. PubMed ID: 30476158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.
    Tang MH; Ching CK; Tsui MS; Chu FK; Mak TW
    Clin Toxicol (Phila); 2014 Jun; 52(5):561-5. PubMed ID: 24779864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
    Steuer AE; Williner E; Staeheli SN; Kraemer T
    Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples.
    Mogler L; Wilde M; Huppertz LM; Weinfurtner G; Franz F; Auwärter V
    Drug Test Anal; 2018 May; 10(5):886-891. PubMed ID: 29314750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.